PL367938A1 - Pochodne fenyloacetamido-tiazolu, sposób ich wytwarzania i ich zastosowanie jako środków przeciwnowotworowych - Google Patents

Pochodne fenyloacetamido-tiazolu, sposób ich wytwarzania i ich zastosowanie jako środków przeciwnowotworowych

Info

Publication number: PL367938A1
Authority: PL; Poland
Prior art keywords: phenylacetamido; preparation; antitumor agents; thiazole derivatives; thiazole
Prior art date: 2001-07-19

Application number

PL02367938A

Other languages

English (en)

Inventor

Paolo Pevarello

Raffaella Amici

Manuela Villa

Barbara Salom

Anna Vulpetti

Mario Varasi

Maria Gabriella Brasca

Gabriella Traquandi

Marcella Nesi

Original Assignee

Pharmacia Italia S.P.A.

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2001-07-19

Filing date

2002-07-02

Publication date

2005-03-07

2002-07-02 Application filed by Pharmacia Italia S.P.A. filed Critical Pharmacia Italia S.P.A.

2005-03-07 Publication of PL367938A1 publication Critical patent/PL367938A1/pl

Links

HYRZQLIFVQELLP-UHFFFAOYSA-N 2-phenyl-n-(1,3-thiazol-2-yl)acetamide Chemical class N=1C=CSC=1NC(=O)CC1=CC=CC=C1 HYRZQLIFVQELLP-UHFFFAOYSA-N 0.000 title 1
239000002246 antineoplastic agent Substances 0.000 title 1

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
- C07D417/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/425—Thiazoles
- A61K31/426—1,3-Thiazoles
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/08—Drugs for disorders of the urinary system of the prostate
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/12—Drugs for disorders of the urinary system of the kidneys
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/06—Antipsoriatics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/14—Drugs for dermatological disorders for baldness or alopecia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A61P35/04—Antineoplastic agents specific for metastasis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
- C07D277/02—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
- C07D277/20—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D277/32—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D277/38—Nitrogen atoms
- C07D277/44—Acylated amino or imino radicals
- C07D277/46—Acylated amino or imino radicals by carboxylic acids, or sulfur or nitrogen analogues thereof

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Life Sciences & Earth Sciences (AREA)
Veterinary Medicine (AREA)
Public Health (AREA)
General Health & Medical Sciences (AREA)
Medicinal Chemistry (AREA)
Animal Behavior & Ethology (AREA)
Pharmacology & Pharmacy (AREA)
General Chemical & Material Sciences (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Chemical Kinetics & Catalysis (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Biomedical Technology (AREA)
Oncology (AREA)
Urology & Nephrology (AREA)
Dermatology (AREA)
Neurosurgery (AREA)
Immunology (AREA)
Neurology (AREA)
Communicable Diseases (AREA)
Vascular Medicine (AREA)
Virology (AREA)
Heart & Thoracic Surgery (AREA)
Hospice & Palliative Care (AREA)
Psychiatry (AREA)
Cardiology (AREA)
Pulmonology (AREA)
Orthopedic Medicine & Surgery (AREA)
Rheumatology (AREA)
Physical Education & Sports Medicine (AREA)
Epidemiology (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Plural Heterocyclic Compounds (AREA)
Thiazole And Isothizaole Compounds (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

PL02367938A 2001-07-19 2002-07-02 Pochodne fenyloacetamido-tiazolu, sposób ich wytwarzania i ich zastosowanie jako środków przeciwnowotworowych PL367938A1 (pl)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
US90794701A	2001-07-19	2001-07-19
US35764202P	2002-02-20	2002-02-20

Publications (1)

Publication Number	Publication Date
PL367938A1 true PL367938A1 (pl)	2005-03-07

Family

ID=26999733

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
PL02367938A PL367938A1 (pl)	2001-07-19	2002-07-02	Pochodne fenyloacetamido-tiazolu, sposób ich wytwarzania i ich zastosowanie jako środków przeciwnowotworowych

Country Status (24)

Country	Link
US (1)	US20040235919A1 (pl)
EP (1)	EP1406899B1 (pl)
JP (1)	JP2004534857A (pl)
KR (1)	KR100908794B1 (pl)
CN (1)	CN1286835C (pl)
AR (1)	AR036176A1 (pl)
AT (1)	ATE345341T1 (pl)
AU (1)	AU2002325860B2 (pl)
BR (1)	BR0211265A (pl)
CA (1)	CA2453294A1 (pl)
CY (1)	CY1105948T1 (pl)
CZ (1)	CZ2004107A3 (pl)
DE (1)	DE60216097T2 (pl)
DK (1)	DK1406899T3 (pl)
EA (1)	EA007392B1 (pl)
ES (1)	ES2274076T3 (pl)
GE (1)	GEP20105095B (pl)
IL (2)	IL159570A0 (pl)
MX (1)	MXPA04000407A (pl)
NO (1)	NO20040210L (pl)
NZ (1)	NZ530524A (pl)
PL (1)	PL367938A1 (pl)
PT (1)	PT1406899E (pl)
WO (1)	WO2003008365A2 (pl)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US7572914B2 (en)	2003-12-19	2009-08-11	Takeda Pharmaceutical Company Limited	Kinase inhibitors
KR20090006885A (ko) *	2004-08-17	2009-01-15	에프. 호프만-라 로슈 아게	치환 히단토인
WO2006023931A2 (en)	2004-08-18	2006-03-02	Takeda San Diego, Inc.	Kinase inhibitors
TW200621766A (en) *	2004-09-17	2006-07-01	Hoffmann La Roche	Substituted hydantoins
US7713973B2 (en)	2004-10-15	2010-05-11	Takeda Pharmaceutical Company Limited	Kinase inhibitors
US8119655B2 (en)	2005-10-07	2012-02-21	Takeda Pharmaceutical Company Limited	Kinase inhibitors
GEP20135728B (en)	2006-10-09	2013-01-25	Takeda Pharmaceuticals Co	Kinase inhibitors
US8168794B2 (en)	2008-03-03	2012-05-01	Novartis Ag	Pim kinase inhibitors and methods of their use
CA2873672A1 (en)	2012-05-21	2013-11-28	Novartis Ag	Novel ring-substituted n-pyridinyl amides as kinase inhibitors
US9938258B2 (en)	2012-11-29	2018-04-10	Karyopharm Therapeutics Inc.	Substituted 2,3-dihydrobenzofuranyl compounds and uses thereof
CN108440515B (zh)	2013-07-03	2022-05-03	卡尔约药物治疗公司	取代的苯并呋喃基和苯并噁唑基化合物及其用途
US9994558B2 (en)	2013-09-20	2018-06-12	Karyopharm Therapeutics Inc.	Multicyclic compounds and methods of using same
EP3337797A1 (en)	2015-08-18	2018-06-27	Karyopharm Therapeutics, Inc.	(s,e)-3-(6-aminopyridin-3-yl)-n-((5-(4-(3-fluoro-3-methylpyrrolidine-1-carbonyl)phenyl)-7-(4-fluorophenyl)benzofuran-2-yl)methyl)acrylamide for the treatment of cancer
US10858347B2 (en)	2015-12-31	2020-12-08	Karyopharm Therapeutics Inc.	Multicyclic compounds and uses thereof
US12110299B2 (en)	2018-09-17	2024-10-08	Yungjin Pharm. Co., Ltd.	Thiazole derivatives and pharmaceutically acceptable salts thereof
WO2021182914A1 (ko) *	2020-03-13	2021-09-16	영진약품 주식회사	신규한 cdk7 억제 화합물 및 이의 약제학적으로 허용가능한 염
CN112979636A (zh) *	2021-02-06	2021-06-18	绍兴文理学院	一种含苯硫醚结构的噻唑类化合物及其制备方法和应用
CN112979634A (zh) *	2021-02-06	2021-06-18	绍兴文理学院	一种含酰胺结构的噻唑类化合物及其制备方法和应用

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US6040321A (en) *	1997-11-12	2000-03-21	Bristol-Myers Squibb Company	Aminothiazole inhibitors of cyclin dependent kinases
US6214852B1 (en) *	1998-10-21	2001-04-10	Bristol-Myers Squibb Company	N-[5-[[[5-alkyl-2-oxazolyl]methyl]thio]-2-thiazolyl]-carboxamide inhibitors of cyclin dependent kinases
GB9823871D0 (en) *	1998-10-30	1998-12-23	Pharmacia & Upjohn Spa	2-Amino-thiazole derivatives, process for their preparation, and their use as antitumour agents
US6114365A (en) *	1999-08-12	2000-09-05	Pharmacia & Upjohn S.P.A.	Arylmethyl-carbonylamino-thiazole derivatives, process for their preparation, and their use as antitumor agents

2002
- 2002-07-02 CZ CZ2004107A patent/CZ2004107A3/cs unknown
- 2002-07-02 BR BR0211265-5A patent/BR0211265A/pt not_active IP Right Cessation
- 2002-07-02 EP EP02760213A patent/EP1406899B1/en not_active Expired - Lifetime
- 2002-07-02 KR KR1020047000859A patent/KR100908794B1/ko not_active Expired - Fee Related
- 2002-07-02 CA CA002453294A patent/CA2453294A1/en not_active Abandoned
- 2002-07-02 US US10/483,620 patent/US20040235919A1/en not_active Abandoned
- 2002-07-02 AU AU2002325860A patent/AU2002325860B2/en not_active Ceased
- 2002-07-02 DE DE60216097T patent/DE60216097T2/de not_active Expired - Lifetime
- 2002-07-02 PT PT02760213T patent/PT1406899E/pt unknown
- 2002-07-02 PL PL02367938A patent/PL367938A1/pl not_active Application Discontinuation
- 2002-07-02 DK DK02760213T patent/DK1406899T3/da active
- 2002-07-02 AT AT02760213T patent/ATE345341T1/de not_active IP Right Cessation
- 2002-07-02 NZ NZ530524A patent/NZ530524A/en not_active IP Right Cessation
- 2002-07-02 JP JP2003513926A patent/JP2004534857A/ja not_active Ceased
- 2002-07-02 EA EA200400208A patent/EA007392B1/ru not_active IP Right Cessation
- 2002-07-02 CN CNB028143388A patent/CN1286835C/zh not_active Expired - Fee Related
- 2002-07-02 GE GEAP200911511A patent/GEP20105095B/en unknown
- 2002-07-02 WO PCT/EP2002/007289 patent/WO2003008365A2/en not_active Ceased
- 2002-07-02 ES ES02760213T patent/ES2274076T3/es not_active Expired - Lifetime
- 2002-07-02 MX MXPA04000407A patent/MXPA04000407A/es active IP Right Grant
- 2002-07-02 IL IL15957002A patent/IL159570A0/xx not_active IP Right Cessation
- 2002-07-18 AR ARP020102690A patent/AR036176A1/es unknown
2004
- 2004-01-16 NO NO20040210A patent/NO20040210L/no not_active Application Discontinuation
2007
- 2007-01-25 CY CY20071100090T patent/CY1105948T1/el unknown
2010
- 2010-04-08 IL IL204947A patent/IL204947A0/en unknown

Also Published As

Publication number	Publication date
EA200400208A1 (ru)	2004-06-24
WO2003008365A3 (en)	2004-02-12
US20040235919A1 (en)	2004-11-25
EP1406899A2 (en)	2004-04-14
DE60216097D1 (de)	2006-12-28
DK1406899T3 (da)	2007-04-02
CY1105948T1 (el)	2011-04-06
DE60216097T2 (de)	2007-06-28
EP1406899B1 (en)	2006-11-15
CA2453294A1 (en)	2003-01-30
GEP20105095B (en)	2010-10-25
KR100908794B1 (ko)	2009-07-22
WO2003008365A2 (en)	2003-01-30
IL204947A0 (en)	2010-11-30
AR036176A1 (es)	2004-08-18
IL159570A0 (en)	2004-06-01
CZ2004107A3 (cs)	2004-04-14
NZ530524A (en)	2006-12-22
CN1286835C (zh)	2006-11-29
BR0211265A (pt)	2004-07-20
KR20040030821A (ko)	2004-04-09
NO20040210L (no)	2004-03-03
ATE345341T1 (de)	2006-12-15
MXPA04000407A (es)	2004-03-18
CN1531535A (zh)	2004-09-22
AU2002325860B2 (en)	2008-03-13
PT1406899E (pt)	2007-01-31
JP2004534857A (ja)	2004-11-18
HK1068336A1 (en)	2005-04-29
EA007392B1 (ru)	2006-10-27
ES2274076T3 (es)	2007-05-16

Legal Events

Date	Code	Title	Description
2012-02-29	REFS	Decisions on refusal to grant patents (taken after the publication of the particulars of the applications)

Publication	Publication Date	Title
IL142372A0 (en)	2002-03-10	2-ureido-thiazole derivatives, process for their preparation, and their use as antitumor agents
IL147923A0 (en)	2002-08-14	3(5)-amino-pyrazole derivatives, process for their preparation and their use as antitumor agents
IL147925A0 (en)	2002-08-14	3(5)-ureido-pyrazole derivatives, process for their preparation and their use as antitumor agents
HUP0202492A3 (en)	2004-12-28	Arylmethyl-carbonylamino-thiazole derivatives process for their preparation and their use as antitumor agents
HUP0201225A3 (en)	2003-11-28	4,5,6,7-tetrahydroindazole derivatives as antitumor agent and process for their preparation
IL142371A0 (en)	2002-03-10	2-amino-thiazole derivatives, process for their preparation, and their use as antitumor agents
TWI319764B (en)	2010-01-21	Mercaptoacetylamide derivatives, a process for their preparation and their use
MXPA03004644A (es)	2003-09-05	Derivados de fenilacetamdia-pirazol y su uso como agentes antitumorales.
IL159570A0 (en)	2004-06-01	Phenylacetamido-thiazole derivatives, process for their preparation and their use as antitumor agents
HUP0302295A3 (en)	2007-03-28	Thienodibenzoazulene derivatives, process for their preparation and use thereof
MXPA03006478A (es)	2003-09-22	Derivados de cromano, procedimiento para su preparacion y su uso como agentes antitumorales.
HUP0402475A3 (en)	2008-10-28	Process for the preparation of [1,4,5]-oxadiazepine derivatives
IL164248A0 (en)	2005-12-18	Acyl-3-carboxyphenylurea derivatives, processes for preparing them and their use
AU2000254308A1 (en)	2001-11-26	Pyrazolopyrimidinone derivatives, process for their preparation and their use
IL156647A0 (en)	2004-01-04	2-arylimino-2,3-dihydrothiazole derivatives, methods for preparing them and therapeutic use thereof
PL365342A1 (pl)	2004-12-27	Pochodne mikanolidu, ich wytwarzanie i zastosowania terapeutyczne
IL157830A0 (en)	2004-03-28	Imidazolidine derivatives, their preparation, and their use as antinflammatory agent
SI1406899T1 (sl)	2007-08-31	Derivati fenilacetamido-tiazola, postopek za njihovo pripravo in njihova uporaba kot antitumorska sredstva
IL160606A0 (en)	2004-07-25	C2-substituted indan-1-ols and their derivatives, processes for their preparation and their use as pharmaceuticals
IL159561A0 (en)	2004-06-01	Eurotinones and derivatives thereof, processes for preparing them, and their use
IL160608A0 (en)	2004-07-25	C2-substituted indan-1-ones and their derivatives, processes for their preparation and their use as pharmaceuticals
AU4240401A (en)	2001-08-27	Pluraflavins and derivatives thereof, process for their preparation and use thereof
IL160938A0 (en)	2004-08-31	Coniosulphides and their derivatives, processes for preparing them, and their use as pharmaceuticals
IL141804A0 (en)	2002-03-10	Benzotriazole-1-yl-uronium derivatives, process for their preparation and use thereof
HUP0303482A3 (en)	2012-12-28	Mercaptoacetylamide derivatives, process for their preparation and their use and pharmaceutical compositions containing them